{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:58:36Z","timestamp":1792119516350,"version":"4.4.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1193648"],"award-info":[{"award-number":["1193648"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002337","name":"Petre Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008436","name":"National Foundation for Medical Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020021","name":"Avant Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2025.e00792","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:18:02Z","timestamp":1763648282000},"page":"e00792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Butyrate modifies epigenetic and immune pathways in peripheral mononuclear cells from children with neurodevelopmental disorders associated with chromatin dysregulation"],"prefix":"10.1016","volume":"23","author":[{"given":"Jessica P.","family":"Hayes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velda X.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke A.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhong","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwani","family":"Dissanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Aryamanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Ellaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian S.","family":"Gloss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekeeb S.","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Valtchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrujna","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7526","key":"10.1016\/j.neurot.2025.e00792_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature13772","article-title":"Synaptic, transcriptional and chromatin genes disrupted in autism","volume":"515","author":"De Rubeis","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00792_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104589","article-title":"CSF neopterin, quinolinic acid and kynurenine\/tryptophan ratio are biomarkers of active neuroinflammation","volume":"91","author":"Yan","year":"2023","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00792_bib3","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.3390\/ijms19113425","article-title":"The impact of nutrition and environmental epigenetics on human health and disease","volume":"19","author":"Tiffon","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00792_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/nan.12608","article-title":"Epigenetics in neurodevelopment","volume":"46","author":"Salinas","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"7766","key":"10.1016\/j.neurot.2025.e00792_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.neurot.2025.e00792_bib6","series-title":"The cell: a molecular approach","article-title":"Chromosomes and chromatin","author":"Cooper","year":"2000"},{"key":"10.1016\/j.neurot.2025.e00792_bib7","article-title":"Chromatin, transcriptional and immune dysregulation in children with neurodevelopmental regression [Internet]","author":"Nishida","year":"2025","journal-title":"medRxiv"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00792_bib8","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200467","article-title":"Intravenous immunoglobulin is associated with epigenetic, ribosomal, and immune changes in paediatric acute-onset neuropsychiatric syndrome","volume":"12","author":"Han","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00792_bib9","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","article-title":"A short guide to histone deacetylases including recent progress on class II enzymes","volume":"52","author":"Park","year":"2020","journal-title":"Exp Mol Med"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00792_bib10","first-page":"1","article-title":"The epigenetic effects of butyrate: potential therapeutic implications for clinical practice","volume":"4","author":"Berni","year":"2012","journal-title":"Clin Epigenet"},{"key":"10.1016\/j.neurot.2025.e00792_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105156","article-title":"Ketogenic diet modifies ribosomal protein dysregulation in KMT2D Kabuki syndrome","volume":"104","author":"Tsang","year":"2024","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00792_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/npp.2016.158","article-title":"The role of the immune system in autism spectrum disorder","volume":"42","author":"Meltzer","year":"2017","journal-title":"Neuropsychopharmacol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00792_bib13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.molmed.2018.06.008","article-title":"The impact of systemic inflammation on neurodevelopment","volume":"24","author":"Jiang","year":"2018","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.neurot.2025.e00792_bib14","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bbi.2023.11.013","article-title":"Comprehensive immunoprofiling of neurodevelopmental disorders suggests three distinct classes based on increased neurogenesis, Th-1 polarization or IL-1 signaling","volume":"115","author":"Sreenivas","year":"2024","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neurot.2025.e00792_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbi.2021.09.009","article-title":"Emerging evidence of toll-like receptors as a putative pathway linking maternal inflammation and neurodevelopmental disorders in human offspring: a systematic review","volume":"99","author":"Han","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00792_bib16","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/mds.22504","article-title":"Immunopathogenic mechanisms in Tourette syndrome: a critical review","volume":"24","author":"Martino","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurot.2025.e00792_bib17","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.pnpbp.2017.12.013","article-title":"The chromatin basis of neurodevelopmental disorders: rethinking dysfunction along the molecular and temporal axes","volume":"84","author":"Gabriele","year":"2018","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00792_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajhg.2017.11.013","article-title":"Histone lysine methylases and demethylases in the landscape of human developmental disorders","volume":"102","author":"Faundes","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.neurot.2025.e00792_bib19","first-page":"1","article-title":"Pathogenic variants in chromatin-related genes: linking immune dysregulation to neuroregression and acute neuropsychiatric disorders","volume":"00","author":"Dale","year":"2025","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.neurot.2025.e00792_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.neurot.2025.e00792_bib21","series-title":"R: a language and environment for statistical computing","year":"2013"},{"key":"10.1016\/j.neurot.2025.e00792_bib22","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Soft"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00792_bib23","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00792_bib24","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00792_bib25","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1111\/j.1528-1167.2011.03394.x","article-title":"Efficacy of the ketogenic diet: which epilepsies respond?","volume":"53","author":"Thammongkol","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurot.2025.e00792_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41421-023-00636-x","article-title":"Ketogenic diet-produced \u03b2-hydroxybutyric acid accumulates brain GABA and increases GABA\/glutamate ratio to inhibit epilepsy","volume":"10","author":"Qiao","year":"2024","journal-title":"Cell Discov"},{"key":"10.1016\/j.neurot.2025.e00792_bib27","unstructured":"Honeycomb Biotechnologies. HIVE CLX scRNAseq solution. [cited 2024 Oct 1]. HIVE CLX sample capture user protocol. Available from: https:\/\/honeycombbio.zendesk.com\/hc\/en-us\/articles\/15173728631707-HIVE-CLX-Sample-Capture-User-Protocol."},{"key":"10.1016\/j.neurot.2025.e00792_bib28","unstructured":"Honeycomb Biotechnologies. HIVE CLX scRNAseq solution. [cited 2024 Oct 1]. HIVE CLX transcriptome recovery & Library preparation user protocol. Available from: https:\/\/honeycombbio.zendesk.com\/hc\/en-us\/articles\/15173667166491-HIVE-CLX-Transcriptome-Recovery-Library-Preparation-User-Protocol."},{"key":"10.1016\/j.neurot.2025.e00792_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.gene.2017.06.056","article-title":"Histone H3 lysine 4 methyltransferase KMT2D","volume":"627","author":"Froimchuk","year":"2017","journal-title":"Gene"},{"issue":"13","key":"10.1016\/j.neurot.2025.e00792_bib30","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1093\/hmg\/ddad059","article-title":"Characterizing the molecular impact of KMT2D variants on the epigenetic and transcriptional landscapes in Kabuki syndrome","volume":"32","author":"Jung","year":"2023","journal-title":"Hum Mol Genet"},{"issue":"16","key":"10.1016\/j.neurot.2025.e00792_bib31","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1093\/hmg\/ddu156","article-title":"CHARGE and Kabuki syndromes: a phenotypic and molecular link","volume":"23","author":"Schulz","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00792_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00792_bib33","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.3390\/ijms24044218","article-title":"MeCP2 is an epigenetic factor that links DNA methylation with brain metabolism","volume":"24","author":"Vuu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.neurot.2025.e00792_bib34","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1038\/s41380-025-03127-5","article-title":"Epigenetic, ribosomal, and immune dysregulation in Paediatric Acute-Onset Neuropsychiatric Syndrome","volume":"30","author":"Han","year":"2025","journal-title":"Mol Psychiatr"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00792_bib35","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ajhg.2017.04.004","article-title":"CHARGE and Kabuki syndromes: gene-specific DNA methylation signatures identify epigenetic mechanisms linking these clinically overlapping conditions","volume":"100","author":"Butcher","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00792_bib36","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1093\/hmg\/ddab183","article-title":"CHARGE syndrome and related disorders: a mechanistic link","volume":"30","author":"Ufartes","year":"2021","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00792_bib37","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41380-020-0773-x","article-title":"Ribosomal protein genes in post-mortem cortical tissue and iPSC-derived neural progenitor cells are commonly upregulated in expression in autism","volume":"26","author":"Lombardo","year":"2021","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.neurot.2025.e00792_bib38","article-title":"Autistic spectrum disorder (ASD) \u2013 gene, molecular and pathway signatures linking systemic inflammation, mitochondrial dysfunction, transsynaptic signalling, and neurodevelopment","volume":"30","author":"Gevezova","year":"2023","journal-title":"Brain Behav Immun Health"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00792_bib39","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1134\/S0006297922140097","article-title":"Epigenetics of ribosomal RNA genes","volume":"87","author":"Denisenko","year":"2022","journal-title":"Biochem Moscow"},{"issue":"18","key":"10.1016\/j.neurot.2025.e00792_bib40","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/hmg\/ddq265","article-title":"CHD7 functions in the nucleolus as a positive regulator of ribosomal RNA biogenesis","volume":"19","author":"Zentner","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00792_bib41","article-title":"KMT2D deficiency promotes myeloid leukemias which is vulnerable to ribosome biogenesis inhibition","volume":"10","author":"Xu","year":"2023","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00792_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jnc.14576","article-title":"Ribosomal biogenesis as an emerging target of neurodevelopmental pathologies","volume":"148","author":"Hetman","year":"2019","journal-title":"J Neurochem"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00792_bib43","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3390\/cells8111379","article-title":"The impact of oxidative stress on ribosomes: from injury to regulation","volume":"8","author":"Shcherbik","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neurot.2025.e00792_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcdb.2022.03.043","article-title":"The homeostatic regulation of ribosome biogenesis","volume":"136","author":"Ni","year":"2023","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.neurot.2025.e00792_bib45","article-title":"Ribosomal control in RNA virus-infected cells","volume":"13","author":"Wang","year":"2022","journal-title":"Front Microbiol"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00792_bib46","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/humu.23026","article-title":"Mutation update for Kabuki syndrome genes KMT2D and KDM6A and further delineation of X-Linked Kabuki Syndrome subtype 2","volume":"37","author":"B\u00f6gershausen","year":"2016","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00792_bib47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/cge.12484","article-title":"Immunologic assessment and KMT2D mutation detection in Kabuki syndrome","volume":"88","author":"Lin","year":"2015","journal-title":"Clin Genet"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00792_bib48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ajmg.a.30722","article-title":"Immune abnormalities are a frequent manifestation of Kabuki syndrome","volume":"135A","author":"Hoffman","year":"2005","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00792_bib49","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ajpath.2017.12.005","article-title":"Chd7 is critical for early T-Cell development and thymus organogenesis in zebrafish","volume":"188","author":"Liu","year":"2018","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00792_bib50","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1542\/peds.2008-3400","article-title":"CHARGE (Coloboma, heart defect, Atresia Choanae, retarded growth and development, genital Hypoplasia, ear Anomalies\/Deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of Immunologic and nonimmunologic phenotypic features","volume":"123","author":"Jyonouchi","year":"2009","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00792_bib51","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.immuni.2015.03.013","article-title":"Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli","volume":"42","author":"Cronk","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.neurot.2025.e00792_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2015.11.003","article-title":"Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory\/excitatory genes in the frontal cortex of an autism model","volume":"102","author":"Kratsman","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neurot.2025.e00792_bib53","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pbb.2014.08.013","article-title":"Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism","volume":"126","author":"Takuma","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neurot.2025.e00792_bib54","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3389\/fimmu.2017.01429","article-title":"Butyrate conditions human dendritic cells to prime type 1 regulatory T cells via both histone deacetylase inhibition and G protein-coupled receptor 109A signaling","volume":"8","author":"Kaisar","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00792_bib55","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41419-023-05853-6","article-title":"Butyrate limits inflammatory macrophage niche in NASH","volume":"14","author":"Sarkar","year":"2023","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00792_bib56","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1080\/10408398.2022.2137776","article-title":"Beneficial effects of butyrate on brain functions: a view of epigenetic","volume":"64","author":"Pereira-Sol","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00792_bib57","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/biores.2012.0223","article-title":"Butyrate histone deacetylase inhibitors","volume":"1","author":"Steliou","year":"2012","journal-title":"Biores Open Access"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00792_bib58","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/sj.bjp.0705682","article-title":"Regulation of microglial inflammatory response by sodium butyrate and short-chain fatty acids","volume":"141","author":"Huuskonen","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurot.2025.e00792_bib59","doi-asserted-by":"crossref","DOI":"10.4161\/sgtp.27539","article-title":"Rho, nuclear actin, and actin-binding proteins in the regulation of transcription and gene expression","volume":"5","author":"Rajakyl\u00e4","year":"2014","journal-title":"Small GTPases"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00792_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12851","article-title":"A nuclear lamina-chromatin-ran GTPase axis modulates nuclear import and DNA damage signaling","volume":"18","author":"Dworak","year":"2019","journal-title":"Aging Cell"},{"issue":"14","key":"10.1016\/j.neurot.2025.e00792_bib61","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.febslet.2008.04.032","article-title":"Chromatin remodelling and actin organisation","volume":"582","author":"Farrants","year":"2008","journal-title":"FEBS Letters"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00792_bib62","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0962-8924(02)00004-1","article-title":"Rho GTPase-activating proteins in cell regulation","volume":"13","author":"Moon","year":"2003","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00792_bib63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/19491034.2020.1742066","article-title":"Emerging roles of cytoskeletal proteins in regulating gene expression and genome organization during differentiation","volume":"11","author":"Xie","year":"2020","journal-title":"Nucleus"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00792_bib64","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3390\/nu12030788","article-title":"Modulation of cellular biochemistry, epigenetics and metabolomics by ketone bodies. Implications of the ketogenic diet in the physiology of the organism and pathological states","volume":"12","author":"D\u0105bek","year":"2020","journal-title":"Nutrients"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00792_bib65","article-title":"Advantages and disadvantages of the ketogenic diet: a review article","volume":"12","author":"Batch","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00792_bib66","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1093\/advances\/nmac036","article-title":"Effects of exogenous ketone supplementation on blood glucose: a systematic review and meta-analysis","volume":"13","author":"Falkenhain","year":"2022","journal-title":"Adv Nutr"},{"key":"10.1016\/j.neurot.2025.e00792_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.947567","article-title":"Ketogenic diets and ketone suplementation: a strategy for therapeutic intervention","volume":"9","author":"Saris","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.neurot.2025.e00792_bib68","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3389\/fphys.2017.00848","article-title":"On the metabolism of exogenous ketones in humans","volume":"8","author":"Stubbs","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.neurot.2025.e00792_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104506","article-title":"Safety and tolerability of sustained exogenous ketosis using ketone monoester drinks for 28 days in healthy adults","volume":"109","author":"Soto-Mota","year":"2019","journal-title":"Regul Toxicol Pharmacol"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00792_bib70","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41551-024-01190-x","article-title":"A serine-conjugated butyrate prodrug with high oral bioavailability suppresses autoimmune arthritis and neuroinflammation in mice","volume":"8","author":"Cao","year":"2024","journal-title":"Nat Biomed Eng"},{"issue":"1_Supplement","key":"10.1016\/j.neurot.2025.e00792_bib71","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4049\/jimmunol.212.supp.0853.5126","article-title":"A pro-drug strategy enhances butyrate bioavailability and therapeutic efficacy in atherosclerosis","volume":"212","author":"Beckman","year":"2024","journal-title":"J Immunol"},{"key":"10.1016\/j.neurot.2025.e00792_bib72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40168-021-01193-9","article-title":"Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation","volume":"10","author":"Bell","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.neurot.2025.e00792_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111385","article-title":"In vivo bioavailability and in vitro toxicological evaluation of the new butyric acid releaser N-(1-carbamoyl-2-phenyl-ethyl) butyramide","volume":"137","author":"Russo","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neurot.2025.e00792_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00105","article-title":"Proteomics Study of peripheral blood mononuclear cells (PBMCs) in autistic children","volume":"13","author":"Shen","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00792_bib75","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13148-023-01582-x","article-title":"Peripheral blood DNA methylation and neuroanatomical responses to HDACi treatment that rescues neurological deficits in a Kabuki syndrome mouse model","volume":"15","author":"Goodman","year":"2023","journal-title":"Clin Epigenet"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:07:19Z","timestamp":1774858039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747925002703"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00792","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Butyrate modifies epigenetic and immune pathways in peripheral mononuclear cells from children with neurodevelopmental disorders associated with chromatin dysregulation","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00792"}}